Mitsui Chemicals (4183) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
11 Nov, 2026Portfolio transformation
Acquisition of JSR is positioned as a portfolio shift toward global specialty materials, not only an expansion of semiconductor materials; further M&A and alliances are part of the strategy.
FY30 target: core operating profit of at least ¥300bn, exceeding the prior ¥250bn goal; EPS growth is intended to lift enterprise value.
The two-axis portfolio centers on L&HC and ICT for growth, and B&GM and Mobility for polymer-chain scale; B&GM separation is planned for FY27.
Growth-area core operating profit growth slowed from 13% in FY19–FY23 to 5% in FY23–FY25; B&GM recorded core operating losses for three consecutive years.
JSR acquisition and ICT positioning
JSR FY25 revenue was ¥440.7bn and operating profit ¥62.3bn; its Digital Solutions business generated ¥252.1bn revenue, ¥63.2bn core operating profit and 25.1% ROS.
JSR brings semiconductor and optical materials, including photoresists, CMP slurries and ALD/CVD materials; its photoresist portfolio ranked No. 2 globally, with CAR and MOR solutions for EUV.
The semiconductor market is forecast to grow at a CAGR of 10% or more from 2025, supporting demand for a broader materials portfolio.
Purchase price is ¥1,392.1bn for 100% of shares; assumed closing debt and other liabilities are ¥447.9bn, and EV/EBITDA is 16x on the FY26 outlook basis.
Closing is expected in H2 FY27, subject to regulatory approvals; DBJ will invest ¥200bn in non-voting preferred shares.
Value creation and synergy targets
Combining customer bases, products and technologies is intended to accelerate development, cross-selling and new product creation across semiconductor and optical materials.
Target incremental synergy by FY35 is ¥40bn: ¥20bn from sales growth and ¥20bn from cost optimization; cost actions include optimizing headquarters, R&D and overseas sites.
FY30 ICT core operating profit target is at least ¥190bn; the FY35 estimate is at least ¥190bn after integration and PPA amortization, with synergy effects included.
The combined portfolio is intended to establish a presence among core semiconductor-market players and make ICT the leading profit pillar of the transformed portfolio.
Latest events from Mitsui Chemicals
- H1 earnings surged, guidance rose, and the ¥1.84tn JSR deal reset growth and funding plans.4183
Q2 2027 - FY2024 guidance targets a rebound to ¥125.0bn in operating income before special items.4183
Q4 2024 - Ambitious 2030 targets leverage ESG, DX, and AI for sustainable growth and operational excellence.4183
ESG presentation - Operating income before special items jumped 88% YoY in 1Q FY2026, led by specialty chemicals and restructuring.4183
Q1 2027 - Specialty chemicals lead profit growth as global expansion and sustainability accelerate.4183
Investor presentation - FY 2026 profit is set to rise on specialty chemicals growth and restructuring, despite external risks.4183
Q4 2026 - Profits fell on Basic & Green Materials weakness, but ICT Solutions and capital returns remain strong.4183
Q3 2026 - Strong YoY growth with positive outlook, but Osaka plant outage adds uncertainty.4183
Q1 2025 - FY2025 profit rebound is forecast despite net income drop and trade policy risks.4183
Q4 2025